Pacira | PCRX - Capital Ordinário





Capital Ordinário Alterar Data
Astellas Pharma JPY 1.79B 1.52M 2026-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Cara Therapeutics USD 9.38M 2.01K 2026-03
Coherus Biosciences USD 121.16M 4.92M 2025-12
Heron Therapeutics USD 188.31M 4.99M 2025-12
Ironwood Pharmaceuticals USD 160K 0 2024-12
J&J USD 2.41B 1.35M 2026-03
Ligand Pharmaceuticals USD 19.66M 19.64M 2025-09
Nektar Therapeutics USD 29.47M 9.09M 2026-03
Novo Nordisk DKK 4.43B 13.25M 2026-06
Omeros USD 611K 17K 2023-12
Pacira USD 39.82M 512K 2026-06
Perrigo USD 138.1M 500K 2026-03
Pfizer USD 5.7B 0 2026-06
Supernus Pharmaceuticals USD 58.16M 124K 2026-06
Teva Pharmaceutical Industries USD 1.16B 1000K 2026-06
Xeris Pharmaceuticals USD 172.56M 6.34M 2026-03
Zoetis USD 420.35M 4.58M 2026-03